US FDA approves Omeros' drug to treat dangerous transplant complication

The U.S. Food and Drug Administration has approved Omeros' drug for a dangerous transplant complication in adults and children two years and older, marking the first treatment to be greenlit for the condition,

FDA Officially Confirms Kava is a Food Under Federal Law

After Reviewing Historical Use and Modern Safety Evidence, Officially Confirms Kava is a Food Under Federal Law

Rising prices and weight-loss drugs are changing the way we eat — and food companies are racing to keep up

A shaky economy, wider adoption of weight-loss drugs, and changing tastes seem to conspire against some food makers.

Agios Pharma shares jump as US FDA expands approval for its blood disorder drug

Shares of Agios Pharmaceuticals jumped nearly 12% premarket on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.

Accelerated cancer drug approvals yield modest survival gains at significant Medicare cost

Early access to new cancer drugs, granted accelerated approval by the U.S. Food and Drug Administration (FDA), has provided mixed benefits for patients while costing Medicare billions of dollars, reveals research published in the journal BMJ Medicine.
STAT

3 drug policy questions to watch in 2026

Below, STAT previews the three key questions that could define a potentially busy year in the worlds of substance use and behavioral health. On the issue of marijuana, the Trump administration has its work cut out for it in 2026.
Feedback